🇺🇸 FDA
Patent

US 8883500

Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherapy

granted A61KA61K2035/124A61K2239/31

Quick answer

US patent 8883500 (Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherapy) held by Northwestern University expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K2035/124, A61K2239/31, A61K40/11, A61K40/428